$186.990
-0.692 (-0.37%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
RVMD-Prognose durch Analyse ähnlicher Charts
Alphio's RVMD stock price prediction model matches the current Revolution Medicines Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $187.27 (+1.83%). The 1-week path is $187.01 (+1.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Revolution Medicines Inc-Aktien kaufen?
Revolution Medicines Inc is a good buy right now due to its recent approval of the drug Rasonque, which has a projected sales potential of $15.1 billion by 2034. The current price is $186.99, with an analyst price target of $259.14 suggesting a 38.3% upside. However, the company is facing significant losses, with a projected EPS of -2.35 for the next earnings report, which is a key risk to consider.
RVMD schloss am Friday bei $186.99, nachdem der Kurs -0.37% fallen
Revolution Medicines Inc (RVMD) last closed at $183.8999939, losing -1.65%. These facts feed the 1-day and 1-week RVMD price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Revolution Medicines Inc (RVMD) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf RVMD am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für RVMD
Historically the probability of a positive October return for RVMD is 100.00%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.